Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression-Reference-Cited by-同舟云学术

Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression

Published:2017-10-28 Issue:1 Volume:25 Page:225-231
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Mitrakas Lampros^ORCID,Gravas Stavros,Papandreou Christos,Koukoulis Georgios,Karasavvidou Foteini,Dimakopoulos Georgios,Weingärtner Karl,Karatzas Anastasios,Zachos Ioannis,Tzortzis Vasilios

Funder

HELLENIC UROLOGICAL ASSOCIATION

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12253-017-0340-1/fulltext.html

Reference26 articles.

1. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM et al (2016) EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. https://doi.org/10.1016/j.eururo.2016.05.041

2. Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Calais Da Silva F, Powell PH et al (2010) Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 57(5):766–773

3. Soloway M, Khoury S (2012) Bladder cancer. 2nd edition 2012: ICUD-EAU; 254, 261. EDITIONS 21, Paris, France